Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 4.53660003 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.53660003 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.36618787 |
4 | detection of other organism (GO:0098543) | 3.94012353 |
5 | neutrophil activation involved in immune response (GO:0002283) | 3.85365455 |
6 | detection of bacterium (GO:0016045) | 3.83965620 |
7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.67123029 |
8 | wound healing, spreading of epidermal cells (GO:0035313) | 3.61531501 |
9 | negative regulation of interleukin-12 production (GO:0032695) | 3.59338030 |
10 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.57391298 |
11 | detection of external biotic stimulus (GO:0098581) | 3.49734298 |
12 | regulation of mast cell degranulation (GO:0043304) | 3.48957723 |
13 | regulation of leukocyte degranulation (GO:0043300) | 3.45285601 |
14 | detection of molecule of bacterial origin (GO:0032490) | 3.42858737 |
15 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.38067480 |
16 | immunoglobulin mediated immune response (GO:0016064) | 3.34792476 |
17 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.34579615 |
18 | response to muramyl dipeptide (GO:0032495) | 3.30084384 |
19 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.28322355 |
20 | leukocyte aggregation (GO:0070486) | 3.22481867 |
21 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.21655486 |
22 | positive regulation of interferon-alpha production (GO:0032727) | 3.18391606 |
23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.18295212 |
24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.18295212 |
25 | endodermal cell differentiation (GO:0035987) | 3.18108314 |
26 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.17909577 |
27 | protein localization to endosome (GO:0036010) | 3.17783147 |
28 | response to peptidoglycan (GO:0032494) | 3.17668686 |
29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.15116966 |
30 | response to host (GO:0075136) | 3.15116966 |
31 | response to host defenses (GO:0052200) | 3.15116966 |
32 | response to interferon-alpha (GO:0035455) | 3.13733361 |
33 | response to host immune response (GO:0052572) | 3.13569543 |
34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13569543 |
35 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.12002725 |
36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.11207952 |
37 | modulation by symbiont of host defense response (GO:0052031) | 3.11207952 |
38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.11207952 |
39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.11207952 |
40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.11207952 |
41 | modulation by symbiont of host immune response (GO:0052553) | 3.11207952 |
42 | detection of biotic stimulus (GO:0009595) | 3.08281178 |
43 | cellular extravasation (GO:0045123) | 3.08040794 |
44 | negative regulation of phagocytosis (GO:0050765) | 3.08015244 |
45 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07169274 |
46 | wound healing, spreading of cells (GO:0044319) | 3.02688395 |
47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.01801129 |
48 | regulation of interferon-alpha production (GO:0032647) | 3.00774186 |
49 | platelet aggregation (GO:0070527) | 2.92365170 |
50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91599574 |
51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.90554129 |
52 | mannose metabolic process (GO:0006013) | 2.87961301 |
53 | regulation of macrophage cytokine production (GO:0010935) | 2.86930131 |
54 | myeloid dendritic cell activation (GO:0001773) | 2.86609210 |
55 | type I interferon signaling pathway (GO:0060337) | 2.86535151 |
56 | cellular response to type I interferon (GO:0071357) | 2.86535151 |
57 | response to type I interferon (GO:0034340) | 2.86168570 |
58 | barbed-end actin filament capping (GO:0051016) | 2.85058866 |
59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84134521 |
60 | granulocyte activation (GO:0036230) | 2.81611835 |
61 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.80966086 |
62 | myeloid dendritic cell differentiation (GO:0043011) | 2.80898234 |
63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.80709543 |
64 | neutrophil activation (GO:0042119) | 2.80064426 |
65 | regulation of regulated secretory pathway (GO:1903305) | 2.79839471 |
66 | respiratory burst (GO:0045730) | 2.79696867 |
67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76408127 |
68 | myeloid cell activation involved in immune response (GO:0002275) | 2.75119730 |
69 | response to protozoan (GO:0001562) | 2.72910097 |
70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.72638162 |
71 | regulation of integrin activation (GO:0033623) | 2.72374339 |
72 | skin morphogenesis (GO:0043589) | 2.71169733 |
73 | response to interferon-beta (GO:0035456) | 2.70704314 |
74 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70295258 |
75 | chondrocyte proliferation (GO:0035988) | 2.69806463 |
76 | germinal center formation (GO:0002467) | 2.69166210 |
77 | actin nucleation (GO:0045010) | 2.68689404 |
78 | defense response to protozoan (GO:0042832) | 2.68022195 |
79 | macrophage activation (GO:0042116) | 2.67906264 |
80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.67546367 |
81 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.66967488 |
82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64390121 |
83 | B cell mediated immunity (GO:0019724) | 2.64263628 |
84 | positive regulation of macrophage differentiation (GO:0045651) | 2.64234541 |
85 | pinocytosis (GO:0006907) | 2.62346437 |
86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.62199815 |
87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.61971074 |
88 | cell adhesion mediated by integrin (GO:0033627) | 2.59857810 |
89 | regulation of protein heterodimerization activity (GO:0043497) | 2.59653582 |
90 | sequestering of actin monomers (GO:0042989) | 2.59329859 |
91 | protein heterotrimerization (GO:0070208) | 2.58821453 |
92 | angiogenesis involved in wound healing (GO:0060055) | 2.58667177 |
93 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.58551796 |
94 | cellular response to interferon-alpha (GO:0035457) | 2.58420797 |
95 | positive regulation of mast cell activation (GO:0033005) | 2.57989638 |
96 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.57924342 |
97 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.56105376 |
98 | positive regulation of receptor recycling (GO:0001921) | 2.56042085 |
99 | natural killer cell differentiation (GO:0001779) | 2.55450070 |
100 | regulation of natural killer cell differentiation (GO:0032823) | 2.55358872 |
101 | NIK/NF-kappaB signaling (GO:0038061) | 2.55293647 |
102 | mature B cell differentiation involved in immune response (GO:0002313) | 2.55272256 |
103 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55270849 |
104 | regulation of monocyte chemotaxis (GO:0090025) | 2.54852729 |
105 | response to laminar fluid shear stress (GO:0034616) | 2.53326283 |
106 | T cell migration (GO:0072678) | 2.53022313 |
107 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52942520 |
108 | regulation of superoxide anion generation (GO:0032928) | 2.52578431 |
109 | regulation of mast cell activation (GO:0033003) | 2.51439542 |
110 | leukocyte cell-cell adhesion (GO:0007159) | 2.51362722 |
111 | dendritic cell differentiation (GO:0097028) | 2.49602131 |
112 | signal complex assembly (GO:0007172) | 2.49426020 |
113 | positive regulation of leukocyte degranulation (GO:0043302) | 2.49047152 |
114 | negative regulation of interleukin-6 production (GO:0032715) | 2.48675021 |
115 | T cell apoptotic process (GO:0070231) | 2.48220154 |
116 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.48185669 |
117 | regulation of T cell tolerance induction (GO:0002664) | 2.47660153 |
118 | modulation by symbiont of host cellular process (GO:0044068) | 2.47323842 |
119 | hypotonic response (GO:0006971) | 2.46919426 |
120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.46681480 |
121 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.46220363 |
122 | negative regulation of type 2 immune response (GO:0002829) | 2.45015696 |
123 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.44941788 |
124 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43604388 |
125 | apoptotic cell clearance (GO:0043277) | 2.43531243 |
126 | phagocytosis, recognition (GO:0006910) | 2.42539886 |
127 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42281335 |
128 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.41813011 |
129 | regulation of chemokine biosynthetic process (GO:0045073) | 2.41784455 |
130 | microglial cell activation (GO:0001774) | 2.41663004 |
131 | regulation of B cell differentiation (GO:0045577) | 2.41539679 |
132 | phagocytosis, engulfment (GO:0006911) | 2.40895699 |
133 | membrane raft organization (GO:0031579) | 2.40159929 |
134 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.39704416 |
135 | negative regulation of innate immune response (GO:0045824) | 2.39646001 |
136 | regulation of monocyte differentiation (GO:0045655) | 2.39228366 |
137 | * stress fiber assembly (GO:0043149) | 2.38945408 |
138 | megakaryocyte development (GO:0035855) | 2.38871460 |
139 | basement membrane organization (GO:0071711) | 2.38717342 |
140 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.36736850 |
141 | amino sugar catabolic process (GO:0046348) | 2.36459570 |
142 | regulation of mononuclear cell migration (GO:0071675) | 2.36238196 |
143 | definitive hemopoiesis (GO:0060216) | 2.36016866 |
144 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.35786836 |
145 | positive regulation of mast cell degranulation (GO:0043306) | 2.35786836 |
146 | regulation of type 2 immune response (GO:0002828) | 2.35600581 |
147 | modulation by virus of host process (GO:0019054) | 2.35531195 |
148 | regulation of extracellular matrix disassembly (GO:0010715) | 2.35112795 |
149 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.34788635 |
150 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.34605420 |
151 | homotypic cell-cell adhesion (GO:0034109) | 2.34568254 |
152 | collagen fibril organization (GO:0030199) | 2.34290709 |
153 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.33478526 |
154 | response to interleukin-15 (GO:0070672) | 2.32852871 |
155 | positive regulation of lamellipodium assembly (GO:0010592) | 2.28736383 |
156 | macrophage activation involved in immune response (GO:0002281) | 2.28282722 |
157 | myeloid cell homeostasis (GO:0002262) | 2.27580636 |
158 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.27568144 |
159 | regulation of necroptotic process (GO:0060544) | 2.27169956 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.02339031 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.74956512 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.67867845 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.50218944 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.35558891 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.28279846 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97023251 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95772152 |
9 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75995218 |
10 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.71250963 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.68828963 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52378581 |
13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.51460356 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50913462 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48760991 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.46303637 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36386744 |
18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29748564 |
19 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28189358 |
20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24461204 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18037435 |
22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17781767 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.17734687 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07243486 |
25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06579239 |
26 | MAF_26560356_Chip-Seq_TH1_Human | 2.04704038 |
27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.98870801 |
28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98459743 |
29 | MYC_22102868_ChIP-Seq_BL_Human | 1.97225663 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96503164 |
31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.93004359 |
32 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.90908640 |
33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88541467 |
34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.84021563 |
35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80534481 |
36 | MYB_26560356_Chip-Seq_TH2_Human | 1.79538433 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78723601 |
38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77353335 |
39 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.71215955 |
40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69614624 |
41 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67479374 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66864696 |
43 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61095650 |
44 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60848337 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60196782 |
46 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.54823966 |
47 | MYB_26560356_Chip-Seq_TH1_Human | 1.52776894 |
48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51646315 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50503988 |
50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47056473 |
51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46347110 |
52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.46259898 |
53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46258184 |
54 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45582846 |
55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45521452 |
56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40442563 |
57 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39627653 |
58 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39449080 |
59 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.39253254 |
60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38411953 |
61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37946764 |
62 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.37419440 |
63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32294593 |
64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31907647 |
65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30088360 |
66 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30007035 |
67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29396402 |
68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29367429 |
69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29085097 |
70 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29073168 |
71 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.28733214 |
72 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.28733214 |
73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25455194 |
74 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23921167 |
75 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23793287 |
76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23571990 |
77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22709206 |
78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19339400 |
79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18749910 |
80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16902227 |
81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16479660 |
82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16189137 |
83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16087781 |
84 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15333794 |
85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14501142 |
86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14456209 |
87 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14373001 |
88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14291245 |
89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13155006 |
90 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12913400 |
91 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12544427 |
92 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.12362173 |
93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12192888 |
94 | MAF_26560356_Chip-Seq_TH2_Human | 1.11835692 |
95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11258925 |
96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11201025 |
97 | P68_20966046_ChIP-Seq_HELA_Human | 1.11174261 |
98 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10083214 |
99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09862405 |
100 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09831956 |
101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09197217 |
102 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.09158519 |
103 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08643567 |
104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08005128 |
105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07862165 |
106 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07781741 |
107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07616659 |
108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07383724 |
109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07143295 |
110 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06040902 |
111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05809809 |
112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05310034 |
113 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05086919 |
114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05031091 |
115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04026988 |
116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03942488 |
117 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02943966 |
118 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02403271 |
119 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01218905 |
120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01109916 |
121 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01107975 |
122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97845075 |
123 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97662126 |
124 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94895366 |
125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93054580 |
126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92562347 |
127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92372564 |
128 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91524993 |
129 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.90336583 |
130 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90151261 |
131 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.89606915 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 3.71967475 |
2 | MP0003436_decreased_susceptibility_to | 3.07985102 |
3 | MP0003279_aneurysm | 2.88656236 |
4 | MP0001835_abnormal_antigen_presentation | 2.79793960 |
5 | MP0009785_altered_susceptibility_to | 2.66930626 |
6 | MP0003191_abnormal_cellular_cholesterol | 2.45923278 |
7 | MP0003303_peritoneal_inflammation | 2.37791590 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.27093010 |
9 | MP0002148_abnormal_hypersensitivity_rea | 2.22401454 |
10 | MP0000685_abnormal_immune_system | 2.20879894 |
11 | MP0002419_abnormal_innate_immunity | 2.13339182 |
12 | MP0003172_abnormal_lysosome_physiology | 2.11924600 |
13 | MP0005000_abnormal_immune_tolerance | 2.08862588 |
14 | MP0006054_spinal_hemorrhage | 2.07407723 |
15 | MP0005025_abnormal_response_to | 2.05515771 |
16 | MP0003724_increased_susceptibility_to | 2.04669609 |
17 | MP0008260_abnormal_autophagy | 2.02585332 |
18 | MP0010352_gastrointestinal_tract_polyps | 1.95574078 |
19 | MP0001958_emphysema | 1.94598816 |
20 | MP0005503_abnormal_tendon_morphology | 1.93369028 |
21 | MP0005671_abnormal_response_to | 1.92011580 |
22 | MP0005023_abnormal_wound_healing | 1.90297532 |
23 | MP0001533_abnormal_skeleton_physiology | 1.89800403 |
24 | MP0002452_abnormal_antigen_presenting | 1.89047896 |
25 | MP0000858_altered_metastatic_potential | 1.85952730 |
26 | * MP0003566_abnormal_cell_adhesion | 1.84573733 |
27 | MP0006082_CNS_inflammation | 1.80822782 |
28 | MP0005464_abnormal_platelet_physiology | 1.80184552 |
29 | MP0009278_abnormal_bone_marrow | 1.78761662 |
30 | MP0005275_abnormal_skin_tensile | 1.78707539 |
31 | MP0000343_altered_response_to | 1.78344819 |
32 | MP0001853_heart_inflammation | 1.78114551 |
33 | MP0004808_abnormal_hematopoietic_stem | 1.75482293 |
34 | MP0009333_abnormal_splenocyte_physiolog | 1.74608645 |
35 | MP0002396_abnormal_hematopoietic_system | 1.74565367 |
36 | MP0003448_altered_tumor_morphology | 1.74126726 |
37 | MP0001790_abnormal_immune_system | 1.73908169 |
38 | MP0005387_immune_system_phenotype | 1.73908169 |
39 | MP0002405_respiratory_system_inflammati | 1.71847286 |
40 | MP0002723_abnormal_immune_serum | 1.68573417 |
41 | MP0001819_abnormal_immune_cell | 1.67414147 |
42 | MP0001800_abnormal_humoral_immune | 1.66979032 |
43 | MP0002420_abnormal_adaptive_immunity | 1.66202761 |
44 | MP0005451_abnormal_body_composition | 1.65233190 |
45 | MP0004510_myositis | 1.56527092 |
46 | MP0004272_abnormal_basement_membrane | 1.56033831 |
47 | MP0005397_hematopoietic_system_phenotyp | 1.55869112 |
48 | MP0001545_abnormal_hematopoietic_system | 1.55869112 |
49 | MP0002933_joint_inflammation | 1.55427760 |
50 | MP0001849_ear_inflammation | 1.50578817 |
51 | MP0003300_gastrointestinal_ulcer | 1.50166056 |
52 | MP0004858_abnormal_nervous_system | 1.47802142 |
53 | MP0003828_pulmonary_edema | 1.46180221 |
54 | MP0010155_abnormal_intestine_physiology | 1.46036364 |
55 | MP0005623_abnormal_meninges_morphology | 1.42203711 |
56 | MP0004947_skin_inflammation | 1.42059446 |
57 | MP0005390_skeleton_phenotype | 1.41755102 |
58 | MP0000767_abnormal_smooth_muscle | 1.41344261 |
59 | * MP0003091_abnormal_cell_migration | 1.39491016 |
60 | MP0010368_abnormal_lymphatic_system | 1.37479273 |
61 | MP0002398_abnormal_bone_marrow | 1.35589064 |
62 | MP0001845_abnormal_inflammatory_respons | 1.26904142 |
63 | MP0000716_abnormal_immune_system | 1.25036114 |
64 | MP0002998_abnormal_bone_remodeling | 1.24151493 |
65 | MP0000733_abnormal_muscle_development | 1.22864601 |
66 | MP0005058_abnormal_lysosome_morphology | 1.17400456 |
67 | MP0002722_abnormal_immune_system | 1.12244290 |
68 | MP0002429_abnormal_blood_cell | 1.11645546 |
69 | MP0000689_abnormal_spleen_morphology | 1.10289801 |
70 | MP0001879_abnormal_lymphatic_vessel | 1.10057952 |
71 | MP0008007_abnormal_cellular_replicative | 1.08965363 |
72 | MP0000465_gastrointestinal_hemorrhage | 1.07409635 |
73 | MP0000490_abnormal_crypts_of | 1.06838763 |
74 | MP0003763_abnormal_thymus_physiology | 1.06192595 |
75 | MP0002166_altered_tumor_susceptibility | 1.04690617 |
76 | MP0001542_abnormal_bone_strength | 1.04342700 |
77 | MP0002060_abnormal_skin_morphology | 1.04029989 |
78 | MP0008004_abnormal_stomach_pH | 1.03256258 |
79 | MP0002877_abnormal_melanocyte_morpholog | 1.02594541 |
80 | MP0009764_decreased_sensitivity_to | 1.02152662 |
81 | MP0002006_tumorigenesis | 1.01473229 |
82 | MP0005508_abnormal_skeleton_morphology | 1.01153750 |
83 | MP0001243_abnormal_dermal_layer | 1.00726975 |
84 | MP0008469_abnormal_protein_level | 0.99741293 |
85 | MP0009384_cardiac_valve_regurgitation | 0.99325130 |
86 | MP0001348_abnormal_lacrimal_gland | 0.98480753 |
87 | MP0000604_amyloidosis | 0.96595387 |
88 | MP0002254_reproductive_system_inflammat | 0.92803363 |
89 | MP0000249_abnormal_blood_vessel | 0.91378790 |
90 | MP0003795_abnormal_bone_structure | 0.90811988 |
91 | MP0003183_abnormal_peptide_metabolism | 0.88878531 |
92 | MP0005076_abnormal_cell_differentiation | 0.86681608 |
93 | MP0005164_abnormal_response_to | 0.86303056 |
94 | MP0003866_abnormal_defecation | 0.85167573 |
95 | MP0005257_abnormal_intraocular_pressure | 0.84728107 |
96 | MP0003045_fibrosis | 0.82622547 |
97 | MP0001851_eye_inflammation | 0.82258278 |
98 | MP0000703_abnormal_thymus_morphology | 0.81744123 |
99 | MP0001614_abnormal_blood_vessel | 0.80413739 |
100 | MP0002128_abnormal_blood_circulation | 0.78934006 |
101 | MP0005166_decreased_susceptibility_to | 0.78293071 |
102 | MP0001915_intracranial_hemorrhage | 0.77001625 |
103 | MP0004883_abnormal_blood_vessel | 0.76913393 |
104 | MP0009840_abnormal_foam_cell | 0.76682513 |
105 | MP0003453_abnormal_keratinocyte_physiol | 0.75595853 |
106 | MP0003075_altered_response_to | 0.74110518 |
107 | MP0003329_amyloid_beta_deposits | 0.73212952 |
108 | MP0002132_abnormal_respiratory_system | 0.73108156 |
109 | MP0005409_darkened_coat_color | 0.73028567 |
110 | MP0001663_abnormal_digestive_system | 0.72964327 |
111 | MP0005595_abnormal_vascular_smooth | 0.72311770 |
112 | MP0010030_abnormal_orbit_morphology | 0.72098004 |
113 | MP0009763_increased_sensitivity_to | 0.69693981 |
114 | MP0002113_abnormal_skeleton_development | 0.69205516 |
115 | MP0005310_abnormal_salivary_gland | 0.69080702 |
116 | MP0001175_abnormal_lung_morphology | 0.66235313 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 5.51097740 |
2 | Premature rupture of membranes (HP:0001788) | 4.74688433 |
3 | Recurrent abscess formation (HP:0002722) | 4.32029784 |
4 | Eczematoid dermatitis (HP:0000976) | 4.25758376 |
5 | Peritonitis (HP:0002586) | 4.09793890 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85010419 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.68766289 |
8 | Vertebral compression fractures (HP:0002953) | 3.59147862 |
9 | Myositis (HP:0100614) | 3.54691148 |
10 | Aortic dissection (HP:0002647) | 3.34259717 |
11 | Cervical subluxation (HP:0003308) | 3.07280311 |
12 | Dilatation of the ascending aorta (HP:0005111) | 2.96188287 |
13 | Orchitis (HP:0100796) | 2.95819647 |
14 | Cerebral aneurysm (HP:0004944) | 2.91138744 |
15 | Spinal cord lesions (HP:0100561) | 2.87502013 |
16 | Syringomyelia (HP:0003396) | 2.87502013 |
17 | Aortic aneurysm (HP:0004942) | 2.86604219 |
18 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85742940 |
19 | Biconcave vertebral bodies (HP:0004586) | 2.85597353 |
20 | Cellulitis (HP:0100658) | 2.85341746 |
21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.83927581 |
22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.83927581 |
23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.83927581 |
24 | Shallow orbits (HP:0000586) | 2.83488423 |
25 | Abnormality of macrophages (HP:0004311) | 2.80467997 |
26 | Osteolytic defects of the hand bones (HP:0009699) | 2.72746849 |
27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.72746849 |
28 | Ankle contracture (HP:0006466) | 2.69683774 |
29 | Mediastinal lymphadenopathy (HP:0100721) | 2.68250243 |
30 | Dysostosis multiplex (HP:0000943) | 2.63855284 |
31 | Atrophic scars (HP:0001075) | 2.52718239 |
32 | Stomatitis (HP:0010280) | 2.51304760 |
33 | Abnormal platelet volume (HP:0011876) | 2.50800600 |
34 | Increased density of long bones (HP:0006392) | 2.46921676 |
35 | Increased IgE level (HP:0003212) | 2.46841954 |
36 | Recurrent fungal infections (HP:0002841) | 2.44976531 |
37 | Increased variability in muscle fiber diameter (HP:0003557) | 2.44045112 |
38 | Petechiae (HP:0000967) | 2.41923419 |
39 | Recurrent skin infections (HP:0001581) | 2.40236754 |
40 | Increased mean platelet volume (HP:0011877) | 2.39563422 |
41 | Amyloidosis (HP:0011034) | 2.38137120 |
42 | Vacuolated lymphocytes (HP:0001922) | 2.35470078 |
43 | Increased cerebral lipofuscin (HP:0011813) | 2.34707584 |
44 | Soft skin (HP:0000977) | 2.34490717 |
45 | Thrombocytosis (HP:0001894) | 2.34425746 |
46 | Wormian bones (HP:0002645) | 2.30465200 |
47 | Abnormality of the peritoneum (HP:0002585) | 2.28921978 |
48 | Obstructive lung disease (HP:0006536) | 2.27577978 |
49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27577978 |
50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27207412 |
51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26732882 |
52 | Broad face (HP:0000283) | 2.26245066 |
53 | Gastrointestinal infarctions (HP:0005244) | 2.24741050 |
54 | Loss of speech (HP:0002371) | 2.24581268 |
55 | Slender build (HP:0001533) | 2.24189443 |
56 | Blue sclerae (HP:0000592) | 2.23521653 |
57 | Interstitial pulmonary disease (HP:0006530) | 2.18143397 |
58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17740216 |
59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17740216 |
60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17740216 |
61 | Nonimmune hydrops fetalis (HP:0001790) | 2.16161813 |
62 | Fragile skin (HP:0001030) | 2.15582978 |
63 | Optic neuritis (HP:0100653) | 2.15524965 |
64 | Retrobulbar optic neuritis (HP:0100654) | 2.15524965 |
65 | Bladder diverticulum (HP:0000015) | 2.15413991 |
66 | Mitral valve prolapse (HP:0001634) | 2.14385796 |
67 | Meningitis (HP:0001287) | 2.14289398 |
68 | Broad metatarsal (HP:0001783) | 2.12457850 |
69 | Genu recurvatum (HP:0002816) | 2.10529445 |
70 | Mucopolysacchariduria (HP:0008155) | 2.09859594 |
71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09859594 |
72 | Polycythemia (HP:0001901) | 2.09674787 |
73 | Disproportionate tall stature (HP:0001519) | 2.09475122 |
74 | Spontaneous hematomas (HP:0007420) | 2.09455890 |
75 | Distal lower limb muscle weakness (HP:0009053) | 2.09334268 |
76 | Abnormality of the calcaneus (HP:0008364) | 2.08413970 |
77 | Chronic otitis media (HP:0000389) | 2.08273556 |
78 | Distal lower limb amyotrophy (HP:0008944) | 2.08133265 |
79 | Increased connective tissue (HP:0009025) | 2.08103562 |
80 | Spinal rigidity (HP:0003306) | 2.05832482 |
81 | Prolonged bleeding time (HP:0003010) | 2.05636809 |
82 | Autoimmune thrombocytopenia (HP:0001973) | 2.04952343 |
83 | Gingivitis (HP:0000230) | 2.03958811 |
84 | Spondylolisthesis (HP:0003302) | 2.03816284 |
85 | Thin bony cortex (HP:0002753) | 2.03736739 |
86 | Episodic fever (HP:0001954) | 2.03120431 |
87 | Aneurysm (HP:0002617) | 2.02794881 |
88 | Hepatosplenomegaly (HP:0001433) | 2.02446539 |
89 | Gingival bleeding (HP:0000225) | 2.01878371 |
90 | Arterial thrombosis (HP:0004420) | 2.01532719 |
91 | Chest pain (HP:0100749) | 1.98830266 |
92 | Arterial tortuosity (HP:0005116) | 1.95843740 |
93 | Recurrent viral infections (HP:0004429) | 1.95635471 |
94 | Abnormality of the acetabulum (HP:0003170) | 1.93233683 |
95 | Impaired platelet aggregation (HP:0003540) | 1.92497687 |
96 | Abnormal platelet function (HP:0011869) | 1.92497687 |
97 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92377349 |
98 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92377349 |
99 | Systemic lupus erythematosus (HP:0002725) | 1.92371752 |
100 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.91306651 |
101 | Obstructive sleep apnea (HP:0002870) | 1.90379246 |
102 | Abnormality of the pericardium (HP:0001697) | 1.90204354 |
103 | Abnormality of dentin (HP:0010299) | 1.90138798 |
104 | Elbow flexion contracture (HP:0002987) | 1.89728446 |
105 | Upper motor neuron abnormality (HP:0002127) | 1.88975103 |
106 | Epistaxis (HP:0000421) | 1.88216711 |
107 | Vasculitis (HP:0002633) | 1.87561784 |
108 | Beaking of vertebral bodies (HP:0004568) | 1.87319391 |
109 | Joint stiffness (HP:0001387) | 1.86459815 |
110 | Polygenic inheritance (HP:0010982) | 1.86147105 |
111 | Leukocytosis (HP:0001974) | 1.85704807 |
112 | Myocardial infarction (HP:0001658) | 1.85202668 |
113 | Flexion contracture of toe (HP:0005830) | 1.84334638 |
114 | Joint contractures involving the joints of the feet (HP:0100492) | 1.84334638 |
115 | Basal ganglia calcification (HP:0002135) | 1.84305832 |
116 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.83640382 |
117 | Axonal loss (HP:0003447) | 1.83559000 |
118 | Acrocyanosis (HP:0001063) | 1.83550118 |
119 | Camptodactyly of toe (HP:0001836) | 1.82647316 |
120 | Achilles tendon contracture (HP:0001771) | 1.82383029 |
121 | Mitral regurgitation (HP:0001653) | 1.81961851 |
122 | Radial bowing (HP:0002986) | 1.81871529 |
123 | Short nail (HP:0001799) | 1.81660650 |
124 | Menorrhagia (HP:0000132) | 1.81602513 |
125 | Purpura (HP:0000979) | 1.80599067 |
126 | Bruising susceptibility (HP:0000978) | 1.80477189 |
127 | Pulmonary infiltrates (HP:0002113) | 1.80303725 |
128 | Hematochezia (HP:0002573) | 1.80053069 |
129 | Abnormality of the nasal mucosa (HP:0000433) | 1.79486809 |
130 | Type 1 muscle fiber predominance (HP:0003803) | 1.78993595 |
131 | Emphysema (HP:0002097) | 1.76888422 |
132 | Poor head control (HP:0002421) | 1.76478534 |
133 | Upper limb amyotrophy (HP:0009129) | 1.76327276 |
134 | Distal upper limb amyotrophy (HP:0007149) | 1.76327276 |
135 | Gastrointestinal inflammation (HP:0004386) | 1.74243713 |
136 | Increased serum ferritin (HP:0003281) | 1.73874368 |
137 | Urticaria (HP:0001025) | 1.73692420 |
138 | Persistence of primary teeth (HP:0006335) | 1.73428224 |
139 | Hypertriglyceridemia (HP:0002155) | 1.73369403 |
140 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.73365860 |
141 | Neonatal short-limb short stature (HP:0008921) | 1.72819610 |
142 | Vascular tortuosity (HP:0004948) | 1.72735065 |
143 | Hemoptysis (HP:0002105) | 1.72723656 |
144 | Coxa vara (HP:0002812) | 1.72389895 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 2.95014372 |
2 | PIM2 | 2.81057420 |
3 | PRPF4B | 2.80102305 |
4 | TRIB3 | 2.70195816 |
5 | TTN | 2.61582793 |
6 | TBK1 | 2.56941267 |
7 | MAP4K1 | 2.38257628 |
8 | NME2 | 2.35121092 |
9 | KIT | 2.22927105 |
10 | MAP3K14 | 2.11147730 |
11 | RPS6KA4 | 2.09096570 |
12 | PKN2 | 1.98553289 |
13 | BLK | 1.97579525 |
14 | SMG1 | 1.92873458 |
15 | MAP2K3 | 1.90620205 |
16 | EPHB1 | 1.89201346 |
17 | JAK3 | 1.88558805 |
18 | IRAK4 | 1.75077323 |
19 | BTK | 1.73524816 |
20 | MAP3K10 | 1.69289105 |
21 | KDR | 1.68259758 |
22 | TYK2 | 1.64182976 |
23 | TRPM7 | 1.64031262 |
24 | PRKD2 | 1.58428617 |
25 | FES | 1.57199885 |
26 | TEC | 1.53469972 |
27 | IKBKB | 1.51872566 |
28 | PAK4 | 1.51368730 |
29 | TGFBR2 | 1.50945535 |
30 | ZAP70 | 1.47526148 |
31 | LRRK2 | 1.45515365 |
32 | RIPK1 | 1.44604728 |
33 | BMX | 1.44454934 |
34 | TGFBR1 | 1.43460594 |
35 | STK10 | 1.42756661 |
36 | TNK2 | 1.42415694 |
37 | GRK6 | 1.41788188 |
38 | IRAK3 | 1.39138875 |
39 | IKBKE | 1.37840315 |
40 | EEF2K | 1.35818896 |
41 | TXK | 1.35518217 |
42 | FLT3 | 1.34806291 |
43 | NEK9 | 1.34557599 |
44 | TESK1 | 1.31150537 |
45 | CDC42BPA | 1.27177641 |
46 | MAP3K13 | 1.25063215 |
47 | CSF1R | 1.25042048 |
48 | PTK6 | 1.22967202 |
49 | MYLK | 1.20903696 |
50 | ICK | 1.19295391 |
51 | TESK2 | 1.18386655 |
52 | MAP3K1 | 1.18042318 |
53 | CSK | 1.15385173 |
54 | HCK | 1.13129724 |
55 | FGR | 1.10437234 |
56 | MAP3K6 | 1.10430395 |
57 | ILK | 1.10340374 |
58 | MARK2 | 1.09999828 |
59 | EPHA3 | 1.08703337 |
60 | DMPK | 1.08417759 |
61 | KSR2 | 1.07981659 |
62 | CLK1 | 1.07545954 |
63 | CDK19 | 1.06971901 |
64 | CHUK | 1.05983797 |
65 | ITK | 1.05623970 |
66 | MAP3K11 | 1.01754660 |
67 | PIM1 | 1.01091064 |
68 | PAK2 | 0.96455749 |
69 | MAP3K3 | 0.94832738 |
70 | MOS | 0.93630488 |
71 | PTK2 | 0.91731051 |
72 | PIK3CG | 0.89939389 |
73 | FGFR4 | 0.89413829 |
74 | JAK1 | 0.88100404 |
75 | DDR2 | 0.87184796 |
76 | TIE1 | 0.85797515 |
77 | PDPK1 | 0.85151626 |
78 | RPS6KA2 | 0.84681402 |
79 | ABL2 | 0.83035998 |
80 | PRKG2 | 0.82294495 |
81 | EPHB2 | 0.81965847 |
82 | LCK | 0.77207524 |
83 | STK38 | 0.76912677 |
84 | PTK2B | 0.71392435 |
85 | DAPK3 | 0.71266856 |
86 | MATK | 0.70990530 |
87 | PDGFRA | 0.70332752 |
88 | ARAF | 0.66407559 |
89 | MAPK7 | 0.65466434 |
90 | LATS2 | 0.64547707 |
91 | MAPKAPK2 | 0.63488481 |
92 | EPHA2 | 0.63404680 |
93 | CDK12 | 0.62816660 |
94 | LIMK1 | 0.62162920 |
95 | JAK2 | 0.60842031 |
96 | MAP3K7 | 0.60822063 |
97 | STK4 | 0.60698030 |
98 | SYK | 0.60651480 |
99 | IRAK2 | 0.59764647 |
100 | HIPK2 | 0.58983670 |
101 | PDK1 | 0.58927330 |
102 | TAOK1 | 0.58757990 |
103 | LYN | 0.57800606 |
104 | SIK3 | 0.56485112 |
105 | NLK | 0.55986396 |
106 | TAOK2 | 0.55619891 |
107 | TLK1 | 0.55358757 |
108 | GRK7 | 0.54437669 |
109 | RPS6KA6 | 0.54071608 |
110 | CDK6 | 0.53152575 |
111 | LMTK2 | 0.52066988 |
112 | MAP3K8 | 0.51841539 |
113 | MAPK12 | 0.51654236 |
114 | FGFR3 | 0.49091538 |
115 | RIPK4 | 0.48962079 |
116 | MARK3 | 0.46673724 |
117 | FYN | 0.46650045 |
118 | PAK1 | 0.45590025 |
119 | PBK | 0.45274648 |
120 | MTOR | 0.43030903 |
121 | DYRK1B | 0.42511780 |
122 | SIK1 | 0.41725211 |
123 | SIK2 | 0.41015531 |
124 | ABL1 | 0.39754818 |
125 | CDK7 | 0.38839953 |
126 | RPS6KC1 | 0.38773029 |
127 | RPS6KL1 | 0.38773029 |
128 | RPS6KB2 | 0.38418855 |
129 | PDGFRB | 0.37976369 |
130 | MAP2K2 | 0.35437037 |
131 | MAP3K12 | 0.34706910 |
132 | ERBB3 | 0.33596814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.95120508 |
2 | Malaria_Homo sapiens_hsa05144 | 2.22819964 |
3 | Shigellosis_Homo sapiens_hsa05131 | 2.13278357 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95417860 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95063681 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94035905 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91454230 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.89296752 |
9 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.87740233 |
10 | Legionellosis_Homo sapiens_hsa05134 | 1.82778740 |
11 | Measles_Homo sapiens_hsa05162 | 1.81035803 |
12 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.79889074 |
13 | Pertussis_Homo sapiens_hsa05133 | 1.79320990 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77249441 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73345903 |
16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72288997 |
17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.70805067 |
18 | Salmonella infection_Homo sapiens_hsa05132 | 1.68605561 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68151393 |
20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.62886546 |
21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62725149 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62720835 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62304371 |
24 | Allograft rejection_Homo sapiens_hsa05330 | 1.61479226 |
25 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.58892612 |
26 | Apoptosis_Homo sapiens_hsa04210 | 1.52844062 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52511654 |
28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.46712463 |
29 | Tuberculosis_Homo sapiens_hsa05152 | 1.46601216 |
30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46135529 |
31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44459085 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44386496 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42018031 |
34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41709558 |
35 | Amoebiasis_Homo sapiens_hsa05146 | 1.40779516 |
36 | Platelet activation_Homo sapiens_hsa04611 | 1.40187842 |
37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37961219 |
38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37476472 |
39 | * Focal adhesion_Homo sapiens_hsa04510 | 1.36155858 |
40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34224758 |
41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32196168 |
42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31803996 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.27076391 |
44 | Influenza A_Homo sapiens_hsa05164 | 1.27057556 |
45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24832477 |
46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24620231 |
47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.24064033 |
48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.20943875 |
49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.20059871 |
50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17708785 |
51 | Phagosome_Homo sapiens_hsa04145 | 1.11343190 |
52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05573107 |
53 | Lysosome_Homo sapiens_hsa04142 | 1.03953027 |
54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03210301 |
55 | Asthma_Homo sapiens_hsa05310 | 1.03063610 |
56 | Adherens junction_Homo sapiens_hsa04520 | 1.00122004 |
57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99680465 |
58 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97484725 |
59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96339247 |
60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96012735 |
61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95915298 |
62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95062423 |
63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94977235 |
64 | Bladder cancer_Homo sapiens_hsa05219 | 0.93950972 |
65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93260878 |
66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89480823 |
67 | Ribosome_Homo sapiens_hsa03010 | 0.89037564 |
68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86954318 |
69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.86298908 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.83731260 |
71 | Prion diseases_Homo sapiens_hsa05020 | 0.81816277 |
72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81416974 |
73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79890257 |
74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79643122 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79161097 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79147173 |
77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78366564 |
78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76116569 |
79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74888818 |
80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74639508 |
81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73650841 |
82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73020143 |
83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72805656 |
84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69660805 |
85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69129347 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67200872 |
87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65439375 |
88 | Glioma_Homo sapiens_hsa05214 | 0.62570900 |
89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62493924 |
90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61976175 |
91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61812018 |
92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.61619288 |
93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60397231 |
94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59092831 |
95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58328611 |
96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57965504 |
97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57733616 |
98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56914982 |
99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56370472 |
100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53739822 |
101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53365442 |
102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52818033 |
103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52808968 |
104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52298117 |
105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49475306 |
106 | Base excision repair_Homo sapiens_hsa03410 | 0.48965821 |
107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46818590 |
108 | DNA replication_Homo sapiens_hsa03030 | 0.46282677 |
109 | Prostate cancer_Homo sapiens_hsa05215 | 0.45392715 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.44228790 |
111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43321188 |
112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40997992 |
113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39477100 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39095610 |
115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39049069 |
116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38659362 |
117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38145478 |
118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37093246 |
119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35924020 |
120 | Melanoma_Homo sapiens_hsa05218 | 0.35829541 |
121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35002997 |